Rangeley Capital, LLC Rallybio Corp Transaction History
Rangeley Capital, LLC
- $116 Billion
- Q3 2025
A detailed history of Rangeley Capital, LLC transactions in Rallybio Corp stock. As of the latest transaction made, Rangeley Capital, LLC holds 83,007 shares of RLYB stock, worth $53,124. This represents 0.04% of its overall portfolio holdings.
Number of Shares
83,007Holding current value
$53,124% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
46Shares Held
28.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.68 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.33 Million0.47% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.32 Million1.34% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.11 Million4.2% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$1.94 Million0.11% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $20.6M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...